Creation of a lipoprotein(a) model to forecast progression-free survival and severe adverse events in metastatic lung adenocarcinoma patients lacking driver genes and with PD-L1 TPS under 50% - Top-Institutions - MDSpire

Creation of a lipoprotein(a) model to forecast progression-free survival and severe adverse events in metastatic lung adenocarcinoma patients lacking driver genes and with PD-L1 TPS under 50%

  • By

  • Sicong Li

  • Yiyuan Cui

  • Yijing Yan

  • Hao Li

  • Yue Jin

  • Yufan Chen

  • Jingjie Yu

  • Li Feng

  • April 24, 2026

  • 0 min

Share

Top Institutions in Infectious Disease

Brief introduction explaining scope and methodology.

  • #1

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Thoracic Oncology
    • Immunotherapy
    • Biomarker Research
  • #2

    Dana-Farber Cancer Institute
    Dana-Farber Cancer Institute

    Boston, MA

    Key Differentiators

    • Thoracic Oncology
    • Immuno-oncology
    • Molecular Epidemiology
  • #3

    MD Anderson Cancer Center
    MD Anderson Cancer Center

    Houston, TX

    Key Differentiators

    • Thoracic Oncology
    • Cancer Immunotherapy
    • Clinical Biomarkers
  • #4

    Johns Hopkins Sidney Kimmel Comprehensive Cancer Center
    Johns Hopkins Sidney Kimmel Comprehensive Cancer Center

    Baltimore, MD

    Key Differentiators

    • Thoracic Oncology
    • Translational Cancer Research
    • Immunotherapy
  • #5

    University of California, San Francisco (UCSF) Helen Diller Family Comprehensive Cancer Center
    University of California, San Francisco (UCSF) Helen Diller Family Comprehensive Cancer Center

    San Francisco, CA

    Key Differentiators

    • Thoracic Oncology
    • Cancer Biomarkers
    • Immunotherapy

Original Source(s)

Related Content